Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

for
Ovarian Cancer
Location: Lexington KY
Sponsor: John R van Nagell

Sex: Female

Age: 24+

Code: NCT04473833

Recruiting

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

for
Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer,
Location: Burlington MA, Horsham PA, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07776691

Phase 3, Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, Hackensack NJ, Philadelphia PA,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase 1, Recruiting

Feasibility of CALM in Patients With Ovarian Cancer

for
Patient Satisfaction, Ovarian Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT06459271

Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

for
Ovarian Cancer
Location: New York NY, Tampa FL, Atlanta GA, Oklahoma City OK,
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03877796

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Philadelphia PA, Minneapolis MN, Houston TX,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase 1, Recruiting

The Better, Harder, Faster, Stronger Study

for
Frailty at Older Adults, Ovarian Cancer, Endometrial Cancer,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: Female

Age: 55+

Code: NCT07220512

Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Philadelphia PA, Wilson NC, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Boston MA, Worcester MA, New York NY, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

for
Ovarian Neoplasms, Breast Neoplasms
Location: Boston MA, Lake Success NY, Morristown NJ, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT04641247

Phase 2, Recruiting

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

for
Breast Cancer, Ovarian Cancer, Cervical Cancer,
Location: Pasadena CA
Sponsor: Kaiser Permanente

Sex: All

Age: 21 - 45

Code: NCT07406087

Recruiting

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

for
Endometrioid Ovarian Cancer, Primary Peritoneal Cancer,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 18+

Code: NCT06856499

Phase 1, Recruiting

EXoPERT EMERALD Clinical Study

for
Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: The Bronx NY, Wappingers Falls NY, Albany NY,
Sponsor: EXoPERT

Sex: All

Age: 45+

Code: NCT07186296

Recruiting

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

for
Ovarian Cancer
Location: Fort Lauderdale FL, Miami FL, Jacksonville FL
Sponsor: University of Miami

Sex: Female

Age: 18+

Code: NCT06412120

Recruiting

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

for
Advanced Ovarian Cancer
Location: Oklahoma City OK, Seattle WA
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03878849

Phase 2, Recruiting

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Ovarian Carcinoma, Recurrent Ovary Cancer,
Location: Boston MA
Sponsor: Elizabeth Stover, MD, PhD

Sex: Female

Age: 18+

Code: NCT06964009

Phase 1, Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05985655

Phase 1, Phase 2, Recruiting

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06545604

Recruiting

Integrated Cancer Repository for Cancer Research

for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT02012699

Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Quebec, Greenfield Park, Montreal, Miami FL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial